McDermott Adds to Life Sciences and Technology Practices with New Partners on Both Coasts
PALO ALTO, CA/WASHINGTON, D.C. (October 22, 2007) — McDermott Will & Emery is pleased to announce the arrival of Kyle Guse and Thomas E. Repke as partners in the Firm's Corporate Department and the Firm's 75+ lawyer Life Sciences & Medical Device Practice Group. Mr. Guse will be joining McDermott's Silicon Valley office as a partner, while Mr. Repke will be a partner in the Firm's Washington, D.C. office. Both partners have a strong concentration in the life sciences industry having represented medical technology and pharmaceutical companies on a variety of corporate transactions. Mr. Guse also has significant experience representing other technology companies, including software and clean-tech companies.
"Tom and Kyle bring to our corporate teams on the East Coast and in Silicon Valley a wealth of M&A and capital markets experience across industries, including the important life sciences sector," said Timothy Alvino, co-head of the Firm's Corporate Department. "The addition of these accomplished attorneys is an important step in the continued growth of our Corporate Department in their respective geographic markets and worldwide."
Mr. Repke focuses his practice on mergers and acquisitions, divestitures, private equity, venture capital, financing transactions, joint ventures, strategic alliances and general corporate counseling. He represents public and private companies in a variety of corporate transactional matters, and he has advised companies in the pharmaceutical, health care, defense, homeland security, telecommunications, technology and media industries.
Mr. Guse has a practice emphasizing mergers and acquisitions, private equity, venture capital and general corporate counseling. His clients include both public and private biotechnology and medical device companies and software and other technology companies.
"Tom's and Kyle's talent will complement our existing life sciences team and further bolster our group of highly skilled corporate, health, intellectual property and trial lawyers," commented Stephen Bernstein, co-head of the Firm's life sciences practice.
"Kyle and Tom have accumulated substantial knowledge in the life sciences sector based on years of experience performing industry-specific legal work and also have the skill sets critical to our Firm's corporate clients across industries," said Mark Mihanovic, head of the Silicon Valley Corporate Department. "Kyle is a great addition to our Silicon Valley corporate practice."
Mr. Repke earned his J.D. from the University of Virginia School of Law and his B.A. from The College of William and Mary. He is admitted to the state bars of Virginia and the District of Columbia. His recent awards include: Washington, D.C. Super Lawyers (2006-2007), Virginia Super Lawyers (2006-2007) and Virginia Business Magazine's Legal Elite for Business Law 2006.
Mr. Guse earned his J.D., cum laude, from the Santa Clara University School of Law and his M.B.A. and B.A. from California State University. Additionally, he was a certified public accountant from 1988 to 1996. Mr. Guse is admitted to practice in California and is a member of the State Bar of California and the American Bar Association.
McDermott's Life Sciences & Medical Devices Practice Group provides fully integrated, multidisciplinary legal services to the life sciences industry. Our group of 75+ lawyers, patent agents and scientific advisors provides the full range of legal services required by life sciences companies, at all stages of their development. The Firm understands the specific needs of companies in this industry and supports them through various stages of their products and services life cycle.
The Firm's corporate practice represents a wide spectrum of business interests around the world, from Global 50 companies to venture backed start-ups, as well as the financial institutions that support those companies. McDermott's highly-skilled corporate lawyers act as strategic advisors to our clients and solve complex legal and business issues to assist clients in the execution of their capital raising and corporate development plans.
